Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors. Researchers at the Johns ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
Dr. Chris Hillman, Global AI Lead at Teradata, joins eSpeaks to explore why open data ecosystems are becoming essential for enterprise AI success. In this episode, he breaks down how openness — in ...
A unique facility in Melbourne containing hundreds of childhood cancer tissue samples has produced a first-of-its-kind ...
Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...
WEST LAFAYETTE, Ind. — The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate ...
New research reveals that cells can sense far beyond their immediate surroundings, a biological ability once thought to ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback